(Q42537936)

English

Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration

scientific article published on December 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

based on heuristic

inferred from title

author name string

Ewer MS

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Jaffe N

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Ried H

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Zietz HA

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Benjamin RS

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

512-515

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Adriamycin. A new anticancer drug with significant clinical activity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Risk factors for doxorubicin-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Adriamycin cardiomyopathy--risk factors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Late doxorubicin-associated cardiotoxicity in children. The possible role of intercurrent viral infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199812%2931%3A6%3C512%3A%3AAID-MPO8%3E3.0.CO%3B2-4

21 January 2018

Identifiers

10.1002/(SICI)1096-911X(199812)31:6<512::AID-MPO8>3.0.CO;2-4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

release_gyf3nkfeerhmnljxdzkcftcfsu

1 reference

https://api.fatcat.wiki/v0/release/gyf3nkfeerhmnljxdzkcftcfsu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42537936&oldid=1961199089"